Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Schroeder

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Antimicrobial Agents and Chemotherapy|April 22, 2020
Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19Markus Hoffmann, Simon Schroeder, Hannah Kleine-Weber, et al.
The Journal of General Virology|October 7, 2017
Transgene expression in the genome of Middle East respiratory syndrome coronavirus based on a novel reverse genetics system utilizing Red-mediated recombination cloningDoreen Muth, Benjamin Meyer, Daniela Niemeyer, et al.
The Lancet. Microbe|May 10, 2021
Interferon antagonism by SARS-CoV-2: a functional study using reverse geneticsSimon Schroeder, Fabian Pott, Daniela Niemeyer, et al.
Frontiers in Pharmacology|January 3, 2022
Corrigendum: Antiviral and Immunomodulatory Effects of <i>Pelargonium sidoides DC.</i> Root Extract EPs<sup>®</sup> 7630 in SARS-CoV-2-Infected Human Lung CellsJan Papies, Jackson Emanuel, Nicolas Heinemann, et al.
Frontiers in Pharmacology|November 11, 2021
Antiviral and Immunomodulatory Effects of <i>Pelargonium sidoides DC.</i> Root Extract EPs® 7630 in SARS-CoV-2-Infected Human Lung CellsJan Papies, Jackson Emanuel, Nicolas Heinemann, et al.
Emerging Microbes & Infections|January 23, 2020
Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirusHannah Kleine-Weber, Simon Schroeder, Nadine Krüger, et al.
Cell|March 7, 2020
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorMarkus Hoffmann, Hannah Kleine-Weber, Simon Schroeder, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 12, 2020
Mammalian deltavirus without hepadnavirus coinfection in the neotropical rodent <i>Proechimys semispinosus</i>Sofia Paraskevopoulou, Fabian Pirzer, Nora Goldmann, et al.
Nature Communications|September 8, 2021
Functional comparison of MERS-coronavirus lineages reveals increased replicative fitness of the recombinant lineage 5Simon Schroeder, Christin Mache, Hannah Kleine-Weber, et al.
Emerging Microbes & Infections|November 29, 2018
Detection of distinct MERS-Coronavirus strains in dromedary camels from Kenya, 2017Stella Kiambi, Victor M Corman, Rina Sitawa, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Antimicrobial Agents and Chemotherapy|April 22, 2020
Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19Markus Hoffmann, Simon Schroeder, Hannah Kleine-Weber, et al.
The Journal of General Virology|October 7, 2017
Transgene expression in the genome of Middle East respiratory syndrome coronavirus based on a novel reverse genetics system utilizing Red-mediated recombination cloningDoreen Muth, Benjamin Meyer, Daniela Niemeyer, et al.
The Lancet. Microbe|May 10, 2021
Interferon antagonism by SARS-CoV-2: a functional study using reverse geneticsSimon Schroeder, Fabian Pott, Daniela Niemeyer, et al.
Frontiers in Pharmacology|January 3, 2022
Corrigendum: Antiviral and Immunomodulatory Effects of <i>Pelargonium sidoides DC.</i> Root Extract EPs<sup>®</sup> 7630 in SARS-CoV-2-Infected Human Lung CellsJan Papies, Jackson Emanuel, Nicolas Heinemann, et al.
Frontiers in Pharmacology|November 11, 2021
Antiviral and Immunomodulatory Effects of <i>Pelargonium sidoides DC.</i> Root Extract EPs® 7630 in SARS-CoV-2-Infected Human Lung CellsJan Papies, Jackson Emanuel, Nicolas Heinemann, et al.
Emerging Microbes & Infections|January 23, 2020
Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirusHannah Kleine-Weber, Simon Schroeder, Nadine Krüger, et al.
Cell|March 7, 2020
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorMarkus Hoffmann, Hannah Kleine-Weber, Simon Schroeder, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 12, 2020
Mammalian deltavirus without hepadnavirus coinfection in the neotropical rodent <i>Proechimys semispinosus</i>Sofia Paraskevopoulou, Fabian Pirzer, Nora Goldmann, et al.
Nature Communications|September 8, 2021
Functional comparison of MERS-coronavirus lineages reveals increased replicative fitness of the recombinant lineage 5Simon Schroeder, Christin Mache, Hannah Kleine-Weber, et al.
Emerging Microbes & Infections|November 29, 2018
Detection of distinct MERS-Coronavirus strains in dromedary camels from Kenya, 2017Stella Kiambi, Victor M Corman, Rina Sitawa, et al.
Pageof 2